The prime minister’s official spokesman showed that the target will be reached until February 15 and the next 17 million people will get their first blows until the end of April, the spokesman added.
The UK is deploying vaccines, which has already noticed that more than 12 million people get their first doses and part of a million to get their doses so far.
Boris Johnson insisted that he had “a lot of confidence” in the blows after considerations were expressed that the Oxford/AstraZeneca vaccine might be less effective against the South African variant.
On a scale at a coronavirus testing facility in Derby, the prime minister said: “We are very confident in all the vaccines we use.
“And I think it’s vital for other people to stay in the brain that we all believe are effective in providing a higher degree of coverage against serious illness and death, which is vital.
“We will continue to examine the results, the effectiveness of vaccine deployment, and in fact it goes very, very temporarily, and we will see how other people start responding to vaccines as we prepare to say what we are going to do. in the week of the 22nd and what kind of roadmap we have to implement. “
Johnson added that he “had no doubt that vaccines will offer a way out” amid fears that the strain might delay the easing of blockade restrictions.
He said: “We that all the vaccines we use, the two vaccines we use lately, are effective in preventing serious illness and death.
“We also think, especially in the case of the Oxford/AstraZeneca vaccine, that there is evidence that it also stops transmission, I think 67% relief in transmission with the Oxford/AstraZeneca vaccine.
READ ALSO: Nadhim Zahawi’s ‘vaccine passports’ exclude
“They continue to gain advantages in our country and in the rest of the people massively as we go through the pandemic and I am convinced that vaccines will offer a way out. “
“With the passage of the day, you can see that medicine is slowly gaining the lead over the disease. “
Mr. Johnson’s comments come after an examination found that the Oxford/AstraZeneca puncture is not effective in preventing a mild illness caused by the South African mutation.
Speaking Monday morning, Health Minister Edward Argar said there is “no evidence” that the Oxford/AstraZeneca puncture is not effective in preventing serious illnesses due to coronavirus.
DO NOT DO NOT The French do not accept macron as true for vaccine handling – recent vote [SURVEY] South African variant: Boris Johnson “trusts” Covid jabs effective [INSIGHT] The vaccine crisis in the EU has “delayed” the economic recovery of the bloc – the uk’s progress [ANALYSIS]
He told Sky News: “There is no evidence that this vaccine is not effective in preventing hospitalization, serious illness and death, that we are finally looking with these vaccines. “
Argar said that “the dominant strains in this country are the South African strain”, with “only a small number of cases”.
Meanwhile, another has revealed that the Pfizer/BioNTech vaccine is effective against the variant that emerged in South Africa.
Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine, said he was “reasonably sure” that existing vaccines would protect against serious diseases of the South African variant.
He told BBC Radio 4’s The World At One that the number of stress cases is “probably particularly higher here” than it had been found.
Professor Evans said: “There are many more and this will spread and cause difficulties in the coming months. “
But he added that he is “optimistic” that the Oxford/AstraZeneca vaccine and other injections would protect against serious illnesses.
Professor Evans said: “I’m pretty sure, and I’d probably agree with the prime minister reluctantly to be optimistic, but I don’t think it’s safe. The prime minister has a point about the probability is (this will decrease hospitalizations and deaths even if it doesn’t save you more benign infections. “